Part,  Chapter, Paragraph

1   II,     5.  5.  3|    evidence for a multi-factorial pathogenesis including genetic deviations
2   II,     5.  5.  3|      level covering aetiology and pathogenesis, development and evaluation
3   II,     5.  5.  3| heterogeneity with respect to its pathogenesis, clinical manifestations,
4   II,     5.  5.  3|        indicates heterogeneity on pathogenesis. Brain Pathol 6:259-274.~
5   II,     5.  8.  3|         conditions with unrelated pathogenesis that make COPD management
6   II,     5. 11.  3|          strongly involved in the pathogenesis, and a series of genetic
7   II,     9.  3.  1|          an important role in the pathogenesis of these alterations although